Contact
searchSearch
HMP Global

January 2013 - FRMC

Adjustments to Inhaled Corticosteroids in Asthma
01/22/2013
A study in adults with mild-to-moderate persistent asthma controlled with low-dose inhaled corticosteroid therapy has demonstrated that adjustments in therapy based on biomarkers or symptoms were no better than standard physician...
A study in adults with mild-to-moderate persistent asthma controlled with low-dose inhaled corticosteroid therapy has demonstrated that adjustments in therapy based on biomarkers or symptoms were no better than standard physician...
A study in adults with...
01/22/2013
First Report Managed Care
Pomalidomide in Multiple Myeloma Patients
01/22/2013
Atlanta—Patients with multiple myeloma who had primary refractory or relapsed and refractory disease had a significant improvement in progression-free and overall survival if they took pomalidomide plus low-dose dexamethasone compared with a...
Atlanta—Patients with multiple myeloma who had primary refractory or relapsed and refractory disease had a significant improvement in progression-free and overall survival if they took pomalidomide plus low-dose dexamethasone compared with a...
Atlanta—Patients with multiple...
01/22/2013
First Report Managed Care
Bendamustine and Rituximab to Treat Mantle Cell Lymphoma
01/22/2013
Atlanta—A phase 2, single-arm, multicenter study found that patients with mantle cell lymphoma who had received up to 3 prior courses of chemotherapy had an overall response rate of 82% to the combination treatment of bendamustine plus...
Atlanta—A phase 2, single-arm, multicenter study found that patients with mantle cell lymphoma who had received up to 3 prior courses of chemotherapy had an overall response rate of 82% to the combination treatment of bendamustine plus...
Atlanta—A phase 2, single-arm,...
01/22/2013
First Report Managed Care
Lenalidomide for Mantle Cell Lymphoma
01/22/2013
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle...
01/22/2013
First Report Managed Care
Ruxolitinib and Erythropoiesis-Stimulating Agents for Myelofibrosis
01/22/2013
Atlanta—A posthoc analysis of a phase 3 study found that patients with myelofibrosis who were receiving erythropoiesis-stimulating agents (ESAs) tolerated the concomitant use of ruxolitinib, a potent janus kinase 1 and 2 inhibitor. The...
Atlanta—A posthoc analysis of a phase 3 study found that patients with myelofibrosis who were receiving erythropoiesis-stimulating agents (ESAs) tolerated the concomitant use of ruxolitinib, a potent janus kinase 1 and 2 inhibitor. The...
Atlanta—A posthoc analysis of a...
01/22/2013
First Report Managed Care
Dabigatran Etexilate and Knee or Hip Replacement Surgery
01/22/2013
A study found that dabigatran etexilate was effective and well tolerated in patients undergoing total knee or hip replacement surgery.
A study found that dabigatran etexilate was effective and well tolerated in patients undergoing total knee or hip replacement surgery.
A study found that dabigatran...
01/22/2013
First Report Managed Care
AMG 145 Lowers LDL-C in Statin-Intolerant Patients
01/22/2013
Los Angeles—Patients with high cholesterol who cannot tolerate statins achieved reductions in low-density lipoprotein cholesterol (LDL-C) after taking AMG 145, an investigational drug, according to a global, phase 2, randomized, double-blind,...
Los Angeles—Patients with high cholesterol who cannot tolerate statins achieved reductions in low-density lipoprotein cholesterol (LDL-C) after taking AMG 145, an investigational drug, according to a global, phase 2, randomized, double-blind,...
Los Angeles—Patients with high...
01/22/2013
First Report Managed Care
Daily Intake of Multivitamin Does Not Reduce Risk of Cardiovascular Disease
01/22/2013
Los Angeles—Male physicians who took a multivitamin every day for more than a decade had similar rates of major cardiovascular events, total myocardial infarction, and total stroke compared with a group that took a placebo, according to a...
Los Angeles—Male physicians who took a multivitamin every day for more than a decade had similar rates of major cardiovascular events, total myocardial infarction, and total stroke compared with a group that took a placebo, according to a...
Los Angeles—Male physicians who...
01/22/2013
First Report Managed Care

Department

News Connection
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
01/22/2013
Over the years, sources of grafts in allogeneic hematopoietic stem-cell transplantation have evolved from bone marrow to filgrastim-stimulated peripheral blood, which has a much higher content of blood progenitor cells. Several large,...
Over the years, sources of grafts in allogeneic hematopoietic stem-cell transplantation have evolved from bone marrow to filgrastim-stimulated peripheral blood, which has a much higher content of blood progenitor cells. Several large,...
Over the years, sources of...
01/22/2013
First Report Managed Care
Conference Insider
Costs Associated with Acute Coronary Syndrome
01/22/2013
Los Angeles—A retrospective database analysis of >37,000 claims from employees and their dependents found that patients with acute coronary syndrome (ACS) had high short-term and long-term disability and related costs that are higher or...
Los Angeles—A retrospective database analysis of >37,000 claims from employees and their dependents found that patients with acute coronary syndrome (ACS) had high short-term and long-term disability and related costs that are higher or...
Los Angeles—A retrospective...
01/22/2013
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Call for Gastric Surgery to be Standard Diabetes Treatment
05/25/2016
People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication.
People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication.
People with diabetes should be...
05/25/2016
First Report Managed Care
News
Montana Lawmakers Propose New Abortion Regulations for Medicaid Reimbursement
01/24/2023
Under the proposed change, providers would be required to have state approval before performing an abortion and submit supporting documents to demonstrate the procedure's medical necessity.
Under the proposed change, providers would be required to have state approval before performing an abortion and submit supporting documents to demonstrate the procedure's medical necessity.
Under the proposed change,...
01/24/2023
First Report Managed Care
Trends in Coronary Revascularization Procedures
08/22/2011
One of the most common major medical procedures provided by the healthcare system in the United States, coronary revascularization, is performed >1 million times each year. The procedure comprises coronary artery bypass graft (CABG)...
One of the most common major medical procedures provided by the healthcare system in the United States, coronary revascularization, is performed >1 million times each year. The procedure comprises coronary artery bypass graft (CABG)...
One of the most common major...
08/22/2011
First Report Managed Care
News
Insurer wants focus on what drives up health costs
03/28/2011
03/28/2011
First Report Managed Care
News
Takeda’s Successor Drug to Actos Fails to Win Approval
04/26/2012
04/26/2012
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2013 Volume 10 Issue 1

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use